zopiclone has been researched along with Dysgeusia in 1 studies
zopiclone: S(+)-enantiomer of racemic zopiclone; azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; was term of zopiclone 2004-2007
zopiclone : A pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position.
Dysgeusia: A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The primary endpoint was the Insomnia Severity Index after four weeks of treatment." | 2.82 | Eszopiclone versus zopiclone in the treatment of insomnia. ( Bittencourt, LR; Braga, LR; Pinto, LR; Treptow, EC; Tufik, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinto, LR | 1 |
| Bittencourt, LR | 1 |
| Treptow, EC | 1 |
| Braga, LR | 1 |
| Tufik, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase III, Non-inferiority, Double-blind, Unicenter Clinical Trial With Two Treatment Arms - Test Group With Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia[NCT01100164] | Phase 3 | 263 participants (Actual) | Interventional | 2011-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for zopiclone and Dysgeusia
| Article | Year |
|---|---|
Eszopiclone versus zopiclone in the treatment of insomnia.
Topics: Adult; Azabicyclo Compounds; Double-Blind Method; Dysgeusia; Eszopiclone; Female; Headache; Humans; | 2016 |